MedPath

Metronidazole

METRONIDAZOLE TABLETS USP

Approved
Approval ID

3193a61d-acc4-445a-8bb9-328568d43937

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 4, 2012

Manufacturers
FDA

STAT Rx USA LLC

DUNS: 786036330

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Metronidazole

PRODUCT DETAILS

NDC Product Code16590-385
Application NumberANDA070027
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateOctober 4, 2012
Generic NameMetronidazole

INGREDIENTS (5)

HYDROGENATED COTTONSEED OILInactive
Code: Z82Y2C65EA
Classification: IACT
METRONIDAZOLEActive
Quantity: 250 mg in 1 1
Code: 140QMO216E
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

Metronidazole

PRODUCT DETAILS

NDC Product Code16590-152
Application NumberANDA070033
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateOctober 4, 2012
Generic NameMetronidazole

INGREDIENTS (5)

METRONIDAZOLEActive
Quantity: 500 mg in 1 1
Code: 140QMO216E
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYDROGENATED COTTONSEED OILInactive
Code: Z82Y2C65EA
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.